CoCl2 induced cardiotoxicity associated with CoCr alloy orthopaedic implants

Sarunya Laovitthayanggoon, M. Helen Grant, Catherine J. Henderson, Rothwelle J. Tate, Susan Currie

Research output: Contribution to journalMeeting abstract

Abstract

Cobalt/chromium (Co/Cr) alloy metal-on-metal bearings used in prosthetic hip replacements can cause adverse effects in some patients because they release metal ions into the bloodstream during wear. Co toxicity may be a cause of many severe systemic manifestations including neurologic and cardiac symptomatology.

This study examines the effects of chronic Co exposure in rats treated for 28 days with CoCl2 (single i.p. injection of 1 mg/kg, daily) and examines Co uptake in vitro into primary adult cardiac fibroblasts (CFs). Co treatment was associated with accumulation into various organs with significant increases detected in liver, kidney and heart (245.31±23.64, 204.80±11.19 and 41.04±4.77 µg/L respectively). Echocardiography performed on the same animals showed functional changes correlating with compromised cardiac contractility. Fractional shortening was significantly reduced in CoCl2–treated rats following 28 days treatment when compared with control animals (54.01%±0.90%% vs 60.29±0.53%%, n=6, p≤0.01) and there was evidence of diastolic dysfunction. In order to investigate how Co may accumulate in the heart, primary adult CFs were isolated and uptake of CoCl2 into CFs was compared with uptake into a standard fibroblast 3T3 cell line (3T3s). Uptake of metal ions was measured using inductively coupled plasma mass spectrometry. Co uptake into both 3T3s and CFs increased to between 0–50 and 0–120 µg/L, respectively as the medium concentration of Co (0–300 µM) increased. Interestingly, uptake of Co into CFs was significantly greater than into 3T3 cells. The greater accumulation of CoCl2 into CFs suggests that Co ions in vivo could accumulate in these cells and have functional consequences on cardiac performance. Overall, our data provides strong evidence that Co accumulates in the heart resulting in cardiac dysfunction. Importantly, we have shown for the first time that Co could accumulate in the heart via efficient uptake into CFs. Future work will focus on determining the underlying mechanism for uptake which could have important therapeutic implications.
LanguageEnglish
Article number9
PagesA4
Number of pages1
JournalHeart
Volume103
Issue numberS2
DOIs
Publication statusPublished - 1 Apr 2017
EventScottish Cardiovascular Forum 2017 - University of Glasgow, Glasgow, United Kingdom
Duration: 4 Feb 20174 Feb 2017

Fingerprint

Orthopedics
Fibroblasts
Metals
3T3 Cells
Ions
Chromium Alloys
Cardiotoxicity
Neurologic Manifestations
Echocardiography
Hip
Mass Spectrometry
Therapeutics
Kidney
Cell Line
Injections
Liver

Keywords

  • cobalt
  • chromium
  • alloys
  • prosthetic hip replacements
  • cardiac fibroblasts
  • cardiac dysfunction
  • orthopaedic implants
  • cardiotoxicity

Cite this

@article{a4fa2cf53098423d88886b061c8b254e,
title = "CoCl2 induced cardiotoxicity associated with CoCr alloy orthopaedic implants",
abstract = "Cobalt/chromium (Co/Cr) alloy metal-on-metal bearings used in prosthetic hip replacements can cause adverse effects in some patients because they release metal ions into the bloodstream during wear. Co toxicity may be a cause of many severe systemic manifestations including neurologic and cardiac symptomatology.This study examines the effects of chronic Co exposure in rats treated for 28 days with CoCl2 (single i.p. injection of 1 mg/kg, daily) and examines Co uptake in vitro into primary adult cardiac fibroblasts (CFs). Co treatment was associated with accumulation into various organs with significant increases detected in liver, kidney and heart (245.31±23.64, 204.80±11.19 and 41.04±4.77 µg/L respectively). Echocardiography performed on the same animals showed functional changes correlating with compromised cardiac contractility. Fractional shortening was significantly reduced in CoCl2–treated rats following 28 days treatment when compared with control animals (54.01{\%}±0.90{\%}{\%} vs 60.29±0.53{\%}{\%}, n=6, p≤0.01) and there was evidence of diastolic dysfunction. In order to investigate how Co may accumulate in the heart, primary adult CFs were isolated and uptake of CoCl2 into CFs was compared with uptake into a standard fibroblast 3T3 cell line (3T3s). Uptake of metal ions was measured using inductively coupled plasma mass spectrometry. Co uptake into both 3T3s and CFs increased to between 0–50 and 0–120 µg/L, respectively as the medium concentration of Co (0–300 µM) increased. Interestingly, uptake of Co into CFs was significantly greater than into 3T3 cells. The greater accumulation of CoCl2 into CFs suggests that Co ions in vivo could accumulate in these cells and have functional consequences on cardiac performance. Overall, our data provides strong evidence that Co accumulates in the heart resulting in cardiac dysfunction. Importantly, we have shown for the first time that Co could accumulate in the heart via efficient uptake into CFs. Future work will focus on determining the underlying mechanism for uptake which could have important therapeutic implications.",
keywords = "cobalt, chromium, alloys, prosthetic hip replacements, cardiac fibroblasts, cardiac dysfunction, orthopaedic implants, cardiotoxicity",
author = "Sarunya Laovitthayanggoon and Grant, {M. Helen} and Henderson, {Catherine J.} and Tate, {Rothwelle J.} and Susan Currie",
year = "2017",
month = "4",
day = "1",
doi = "10.1136/heartjnl-2017-311433.9",
language = "English",
volume = "103",
pages = "A4",
journal = "Heart",
issn = "1355-6037",
number = "S2",

}

CoCl2 induced cardiotoxicity associated with CoCr alloy orthopaedic implants. / Laovitthayanggoon, Sarunya; Grant, M. Helen; Henderson, Catherine J.; Tate, Rothwelle J.; Currie, Susan.

In: Heart , Vol. 103, No. S2, 9, 01.04.2017, p. A4.

Research output: Contribution to journalMeeting abstract

TY - JOUR

T1 - CoCl2 induced cardiotoxicity associated with CoCr alloy orthopaedic implants

AU - Laovitthayanggoon, Sarunya

AU - Grant, M. Helen

AU - Henderson, Catherine J.

AU - Tate, Rothwelle J.

AU - Currie, Susan

PY - 2017/4/1

Y1 - 2017/4/1

N2 - Cobalt/chromium (Co/Cr) alloy metal-on-metal bearings used in prosthetic hip replacements can cause adverse effects in some patients because they release metal ions into the bloodstream during wear. Co toxicity may be a cause of many severe systemic manifestations including neurologic and cardiac symptomatology.This study examines the effects of chronic Co exposure in rats treated for 28 days with CoCl2 (single i.p. injection of 1 mg/kg, daily) and examines Co uptake in vitro into primary adult cardiac fibroblasts (CFs). Co treatment was associated with accumulation into various organs with significant increases detected in liver, kidney and heart (245.31±23.64, 204.80±11.19 and 41.04±4.77 µg/L respectively). Echocardiography performed on the same animals showed functional changes correlating with compromised cardiac contractility. Fractional shortening was significantly reduced in CoCl2–treated rats following 28 days treatment when compared with control animals (54.01%±0.90%% vs 60.29±0.53%%, n=6, p≤0.01) and there was evidence of diastolic dysfunction. In order to investigate how Co may accumulate in the heart, primary adult CFs were isolated and uptake of CoCl2 into CFs was compared with uptake into a standard fibroblast 3T3 cell line (3T3s). Uptake of metal ions was measured using inductively coupled plasma mass spectrometry. Co uptake into both 3T3s and CFs increased to between 0–50 and 0–120 µg/L, respectively as the medium concentration of Co (0–300 µM) increased. Interestingly, uptake of Co into CFs was significantly greater than into 3T3 cells. The greater accumulation of CoCl2 into CFs suggests that Co ions in vivo could accumulate in these cells and have functional consequences on cardiac performance. Overall, our data provides strong evidence that Co accumulates in the heart resulting in cardiac dysfunction. Importantly, we have shown for the first time that Co could accumulate in the heart via efficient uptake into CFs. Future work will focus on determining the underlying mechanism for uptake which could have important therapeutic implications.

AB - Cobalt/chromium (Co/Cr) alloy metal-on-metal bearings used in prosthetic hip replacements can cause adverse effects in some patients because they release metal ions into the bloodstream during wear. Co toxicity may be a cause of many severe systemic manifestations including neurologic and cardiac symptomatology.This study examines the effects of chronic Co exposure in rats treated for 28 days with CoCl2 (single i.p. injection of 1 mg/kg, daily) and examines Co uptake in vitro into primary adult cardiac fibroblasts (CFs). Co treatment was associated with accumulation into various organs with significant increases detected in liver, kidney and heart (245.31±23.64, 204.80±11.19 and 41.04±4.77 µg/L respectively). Echocardiography performed on the same animals showed functional changes correlating with compromised cardiac contractility. Fractional shortening was significantly reduced in CoCl2–treated rats following 28 days treatment when compared with control animals (54.01%±0.90%% vs 60.29±0.53%%, n=6, p≤0.01) and there was evidence of diastolic dysfunction. In order to investigate how Co may accumulate in the heart, primary adult CFs were isolated and uptake of CoCl2 into CFs was compared with uptake into a standard fibroblast 3T3 cell line (3T3s). Uptake of metal ions was measured using inductively coupled plasma mass spectrometry. Co uptake into both 3T3s and CFs increased to between 0–50 and 0–120 µg/L, respectively as the medium concentration of Co (0–300 µM) increased. Interestingly, uptake of Co into CFs was significantly greater than into 3T3 cells. The greater accumulation of CoCl2 into CFs suggests that Co ions in vivo could accumulate in these cells and have functional consequences on cardiac performance. Overall, our data provides strong evidence that Co accumulates in the heart resulting in cardiac dysfunction. Importantly, we have shown for the first time that Co could accumulate in the heart via efficient uptake into CFs. Future work will focus on determining the underlying mechanism for uptake which could have important therapeutic implications.

KW - cobalt

KW - chromium

KW - alloys

KW - prosthetic hip replacements

KW - cardiac fibroblasts

KW - cardiac dysfunction

KW - orthopaedic implants

KW - cardiotoxicity

UR - http://heart.bmj.com/content/103/Suppl_2/A4.2

UR - https://www.scf.strath.ac.uk/

U2 - 10.1136/heartjnl-2017-311433.9

DO - 10.1136/heartjnl-2017-311433.9

M3 - Meeting abstract

VL - 103

SP - A4

JO - Heart

T2 - Heart

JF - Heart

SN - 1355-6037

IS - S2

M1 - 9

ER -